Cel Sci Corporation (CVM)

[Fosco1]

Right George

Sorry for my late response to Remit and You.

I factored in a 86% overall survival at year 1 in my models through an ofsett of normal patients survival for this condition, so that you "only" have 14% of patients dying at year 1, including those who die of other causes, this should hopefully fix this concern, we have no certainty on how the physicians decided to select their patients (fragilness, comorbidities) so that they do not die while taking the drug and being treated by SOC.